Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2-((5-((4-fluorophenyl)carbamoyl)pyrimidin-2-yl)sulfanylmethyl)-4-(trifluoromethoxy)phenyl)boronic Acid
2. Incb057643
1. Sx-682
2. 1648843-04-2
3. Unii-h5212r2dpm
4. H5212r2dpm
5. (2-(((5-((4-fluorophenyl)carbamoyl)pyrimidin-2-yl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronic Acid
6. [2-[[5-[(4-fluorophenyl)carbamoyl]pyrimidin-2-yl]sulfanylmethyl]-4-(trifluoromethoxy)phenyl]boronic Acid
7. (2-(((5-((4-fluorophenyl)carbamoyl)pyrimidin-2-yl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronicacid
8. B-(2-(((5-(((4-fluorophenyl)amino)carbonyl)-2-pyrimidinyl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronic Acid
9. Boronic Acid, B-(2-(((5-(((4-fluorophenyl)amino)carbonyl)-2-pyrimidinyl)thio)methyl)-4-(trifluoromethoxy)phenyl)-
10. Chembl4297480
11. Gtpl10165
12. Sx682
13. Bcp32154
14. Ex-a4295
15. Mfcd28502254
16. S8947
17. Sx 682; Sx682
18. Sb17394
19. Ac-36549
20. Hy-119339
21. Cs-0067128
22. D81536
| Molecular Weight | 467.2 g/mol |
|---|---|
| Molecular Formula | C19H14BF4N3O4S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 7 |
| Exact Mass | 467.0734199 g/mol |
| Monoisotopic Mass | 467.0734199 g/mol |
| Topological Polar Surface Area | 130 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 606 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A SX-682 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SX-682, including repackagers and relabelers. The FDA regulates SX-682 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SX-682 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A SX-682 supplier is an individual or a company that provides SX-682 active pharmaceutical ingredient (API) or SX-682 finished formulations upon request. The SX-682 suppliers may include SX-682 API manufacturers, exporters, distributors and traders.
SX-682 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SX-682 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SX-682 GMP manufacturer or SX-682 GMP API supplier for your needs.
A SX-682 CoA (Certificate of Analysis) is a formal document that attests to SX-682's compliance with SX-682 specifications and serves as a tool for batch-level quality control.
SX-682 CoA mostly includes findings from lab analyses of a specific batch. For each SX-682 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SX-682 may be tested according to a variety of international standards, such as European Pharmacopoeia (SX-682 EP), SX-682 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SX-682 USP).
LOOKING FOR A SUPPLIER?
